3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
4
Uterine Cervical Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Carcinoma, Squamous Cell
3
Rectal Neoplasms
2
Head and Neck Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma
2
Adenocarcinoma Of Esophagus
2
Tonsillar Neoplasms
1
Resectable Esophageal Cancer
1
Pharyngeal Neoplasms
1
Neoplasms by Site
1
Neoplasms
1
Muscle Invasive Bladder Cancer
1
Melanoma
1
Lung Neoplasms
1
Limited Stage Small Cell Lung Cancer
1
Glioblastoma
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Adenosquamous
1
Brain Neoplasms
1
Adenocarcinoma
1
Interventions
Irinotecan
3
pembrolizumab
2
Oxaliplatin
2
Leucovorin
2
Fluorouracil
2
trifluridine tipiracil drug combination
1
pralsetinib
1
napabucasin
1
alectinib
1
S-1 plus cisplatin
1
Levoleucovorin
1
KRN-330
1
Indocyanine Green
1
Imatinib Mesylate
1
Fluorescein
1
Docetaxel
1
Cyclophosphamide
1
Calcium Dobesilate
1
Bupivacaine
1
Bevacizumab
1
Ascorbic Acid
1
5,10-methylenetetrahydrofolic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Gastrointestinal Diseases
×
Chemoradiotherapy
×
Clear all
No trials found.